Who is sponsoring NCT04480112?

NCT04480112 is sponsored by Boston University.

What drugs are being tested in NCT04480112?

Interventions in NCT04480112: Technology based social interactions, No research related technology based social interactions.

What condition does NCT04480112 study?

NCT04480112 studies Memory Disorders, Alzheimer Disease, Mild Cognitive Impairment.

Is NCT04480112 still recruiting?

NCT04480112 is currently completed. Last updated 30 August 2021.

Last reviewed 2021-08-30 · How we verify

NCT04480112

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Covid-19 on Frequent Social Interaction Through Communication Technologies in the Cognitive Status of Socially-isolated Older Adults

Completed NA Last updated 30 August 2021

What this trial tests

NA trial testing Technology based social interactions in Memory Disorders in 196 participants. Completed in 11 June 2021.

Timeline

2 June 2020

Primary endpoint
11 June 2021

11 June 2021

Quick facts

Lead sponsor	Boston University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	crossover
Masking	single
Primary purpose	other
Enrollment	196
Start date	2 June 2020
Primary completion	11 June 2021
Estimated completion	11 June 2021
Sites	1 location across United States

Drugs / interventions tested

Technology based social interactions
No research related technology based social interactions

Conditions studied

Memory Disorders — all drugs for Memory Disorders →
Alzheimer Disease — all drugs for Alzheimer Disease →
Mild Cognitive Impairment — all drugs for Mild Cognitive Impairment →

Sponsor

Boston University

Who can join

Eligibility, any sex, with Memory Disorders or Alzheimer Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The current study will examine the impact of frequent social interaction through communication technologies during COVID-19 pandemic in the cognitive status of socially-isolated older adults with and without cognitive impairment. Patients will take place in an experimental crossover study, participants will complete one month of an intervention and one month of as passive control. The goal of this study is to determine: A.) if frequent social interaction through ICT during COVID-19 pandemic will have a significant positive impact in cognitive performance on testing, and B.) how social isolation and cognitive status influence misconceptions around the current pandemic.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Impact of remote social interaction during the COVID-19 pandemic on the cognitive and psychological status of older adults with and without cognitive impairment: A randomized controlled study.
Vives-Rodriguez AL, Marin A, Schiloski KA, Hajos GP, et al · · 2024 · cited 1× · PMID 39531433 · DOI 10.1371/journal.pone.0311792
Older Adults With Cognitive Impairment Can Correct COVID-19 Health-Related Misconceptions.
DeCaro RE, Marin A, Waskow E, Vives-Rodriguez A, et al · · 2026 · PMID 41480626 · DOI 10.1002/hsr2.71519
Characteristics of Home and Neighborhood Built Environments During COVID-19 for Older Adults in the United States and Italy.
Anderson DC, DeCaro RE, Chadalavada M, Marin A, et al · · 2023 · PMID 39055175 · DOI 10.1080/26892618.2023.2269552

Verify or expand the search:

Other recruiting trials for Memory Disorders

Currently open trials in the same condition.

NCT06260228 — HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH)-Parkinson's Disease (HOBSCOTCH-Parkinson's) · NA · active not recruiting
NCT06145737 — HOme-Based Self-management and COgnitive Training CHanges Lives (HOBSCOTCH) - Multiple Sclerosis (MS) · NA · active not recruiting
NCT06427265 — Machine Learning-based Longitudinal Study of Post-ICU Syndrome Development Trajectory in Critically Ill Patients and Con · recruiting
NCT06124339 — Brain Health Virtual Reality Study · NA · recruiting
NCT05709210 — Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease · NA · recruiting

Other Boston University trials

Trials by the same sponsor.

NCT07199634 — Integrating U=U Into HIV Counseling in South Africa (INTUIT-2.0) · NA · not yet recruiting
NCT05838378 — Cigarillo Warnings Image Sorting Study · NA · completed
NCT06088277 — Texting to Reduce Human Immunodeficiency Virus (HIV) Risk · NA · recruiting
NCT06455111 — Evaluation of an Artificial Intelligence-Assisted, Image-Based Dietary Assessment Tool in the Framingham Heart Study · NA · completed
NCT06003439 — Vaping Prevention and Vaping in Youth (Vapechat) · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04480112 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Boston University
Last refreshed: 30 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04480112.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing